To determine directly the effects of streptomycin on translational fidelity in intact cells, we studied the synthesis of f3-galactosidase and of the coat protein of bacteriophage R17 in an Escherichia coli mutant in which the bactericidal effects of streptomycin are delayed. After the addition of streptomycin to exponentially growing mutant cells, protein synthesis continues at an undiminished rate for approximately an hour; however, as measured by enzyme assays, little functional protein is produced. Serological assays designed to detect f3-galactosidase and bacteriophage R17 coat protein show that substantial amounts of the protein synthesized can react with antisera prepared against active ,-galactosidase and phage R17, indicating the aberrance of the protein produced in the presence of the antibiotic. The polypeptides synthesized in the presence of streptomycin are degraded in the cell to a much greater extent than protein synthesized in the absence of the antibiotic. The proteolytic attack on this protein is not affected by inhibitors of serine proteases, suggesting that enzymes other than those involved in "normal turnover" of cellular protein are responsible. In this strain, certain of the multiple effects of streptomycin are separated in time and the production of abnormal protein (enzymatically inactive and susceptible to proteolytic attack) could be studied in the absence of the lethal effect of the drug.
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Streptomycin, in wild-type sensitive bacteria, causes rapid inhibition of protein synthesis in growing cells and in cell-free systems programmed with natural messenger ribonucleic acid (mRNA) (18) . Inaccurate translation of the genetic code has been clearly demonstrated in vitro in response to synthetic mRNAs and has been suggested in vivo by the action of streptomycin as an external suppressor of nonsense and missense mutations (7) and by the apparent production of a cross-reacting protein in response to neomycin (2) . Studies of the miscoding phenomenon in intact cells are difficult because concentrations of the antibiotic that induce errors in translation also cause rapid cessation of protein synthesis and a dramatic loss of viability. To separate the lethal effects of streptomycin from the induction of translational errors, we examined protein synthesis in a strain of Escherichia coli that continues to synthesize protein long after cell division has been inhibited.
A number of E. coli mutants have been reported (3, 8) presence of streptomycin, although no increase in the number of cells is found. Preliminary studies (3) showed that although there was a net increase in protein per cell in the presence of the drug there was little or no increase in functional protein as measured by enzyme activity assays. This observation suggested one of the following alternatives: (i) selective inhibition of protein synthesis; (ii) synthesis of inactive forms of protein as a result of incorporation of incorrect amino acids or premature chain termination; and (iii) increased general or specific degradation.
The synthesis and fate of several proteins were studied in this mutant, and the conclusion was reached that protein serologically related to the functional protein was synthesized in the presence of streptomycin. The protein made in streptomycin-treated cells was not only nonfunctional but particularly susceptible to attack by proteolytic enzyme(s).
MATERIALS AND METHODS
Bacterial strains and medium. The strain used was a streptomycin-independent mutant that arose spontaneously from a streptomycin-dependent parent. The dependent was derived from E. coli Hfrl, a PINKE1T AND BROWNSTEIN methionine-requiring strain which can serve as host for bacteriophage R17 and which is inducible for f,-galactosidase (EC 3.2.1.23) synthesis. The strain carries a mutation in the strA locus, as well as a second mutation which suppresses the requirement for streptomycin for growth and results in an alteration in 30S ribosomal protein S4.
The cells were grown in tris(hydroxymethyl)aminomethane (Tris)-maleate medium (12) supplemented with methionine (20 gg/ml), Casamino Acids (Difco; 0.05%), and glycerol (0.4%). When the cultures were infected with phage R17, CaCl, (5 x 10-3 M) was added immediately prior to the phage inoculum.
Immunological assay for 3B-galactosidase CRM.
The assay for cross-reacting material (CRM) was based on the method of Nakada and Magasanik (11 (specific activity 316 mCi/mmol) per ml of culture medium was added to an exponentially growing culture of mutant cells. Immediately after addition of the labeled amino acid, streptomycin (100 ug/ml) was added to half the culture. After various periods of exposure to the labeled phenylalanine or arginine, incorporation was stopped by the addition of 100-fold excess of the unlabeled amino acid and chloramphenicol (100 ug/ml). The amount of labeled amino acid in each culture that was precipitable with 5% cold trichloroacetic acid at the time of chloramphenicol addition was considered 100% (zero degradation). At intervals after chloramphenicol addition, samples were removed into cold 5% trichloroacetic acid, and the precipitates were collected on glass-fiber filters, washed with a 5% trichloroacetic acid solution containing Casamino Acids, dried, and counted. Protein degradation was measured as loss of radioactivity from the acid-precipitable into the acid-soluble fraction.
Reagents. O-nitrophenyl-,-D-galactopyranoside, 
RESULTS
Effects of streptomycin on protein synthesis. The mutant used in these studies has properties similar to other revertants described previously (3, 9) . It grows exponentially in media containing up to 10 jig of streptomycin per ml. At high concentrations, no colonies appear on solid medium; in liquid culture, there is no increase in the number of viable cells. In contrast to wild-type sensitive cells, however, no loss of viability is noted for at least one generation. For approximately 1 h after addition of streptomycin (100 ug/ml) to growing cultures, the viable cell number remains constant and the mass of the culture doubles. Protein synthesis, as measured by a change in adsorption at 420 nm or by incorporation of a radioactive amino acid, continues in the presence of this streptomycin concentration (Fig. 1) . For the first 30 min the rate of synthesis is the same in the drug-treated culture and the nontreated control. After one generation, the amount of protein synthesized in the streptomycin-treated culture is >80% of that in the control. Assays for #-galactosidase (Fig. 1) indicate little increase in enzyme activity with cessation of active enzyme synthesis occurring between 5 and 10 min after addition of the antibiotic. Assays for other enzymes, both induced and constitutive (serine deaminase, ribonuclease, alkaline phosphatase, and malate dehydrogenase), showed a similar pattern; in no case was there more than 20% increase in any enzyme activity when total protein had increased by 100%.
To determine the nature of protein synthesized in the presence of streptomycin, we used a serological assay technique for detecting the synthesis of proteins related to #-galactosidase and to a structural protein, the coat protein of phage R17.
Synthesis of gi-galactosidase in streptomycin-treated cells. The number of enzyme units that must be used to cause a fixed quantity of antiserum to reach the equivalence point (the point of maximal aggregation of antigen and antibody) is constant. If enzymatically inactive but serologically CRM is present in an extract, the equivalence point for that particular quantity of antiserum will be reached Fig. 2 and 3 . The protein synthesized during aB-Galactosidase synthesis was induced in an exponentially growing culture. At 1 min after addition of isopropyl-8-D-thiogalactopyranoside (10 -a M), streptomycin (100 ,g/ml) was added to half of the culture.
Incubation of both cultures was continued for 40 min. Cells were collected and disrupted in a French pressure cell. The levels of active ,8-galactosidase in the extracts from the streptomycin-treated and nontreated cultures were determined by the method of Pardee et al. (13) , and the level in the non-antibiotictreated extract was adjusted with phosphate buffer (0.1 M, pH 7) to that observed in the streptomycintreated extract to achieve equivalent numbers of active enzyme units in both extracts. ,-Galactosidase was immunologically precipitated, and after the antibody-antigen complex was removed the supernatant fractions were assayed for nonprecipitable ,B-galactosidase activity. +, Enzyme activity; -, no detectable enzyme activity in the supernatant fraction. either a 20-or 40-min exposure to the antibiotic was degraded appreciably faster than that synthesized in the nontreated controls. One hour after termination of synthesis in the sample exposed to streptomycin for 40 min (Fig. 2) particles are produced when the infected cells are exposed to streptomycin (drug added at least 10 min after infection to allow for penetration of phage ribonucleic acid and the synthesis of phage replicase), protein that can be precipitated with serum made against the phage is produced. In the absence of an assay for the functionality of this protein, it is not possible to tell whether the protein made is identical to normal coat protein or is CRM. The protein produced is highly susceptible to degradation. Figure 3 shows the loss of acid-precipitable material synthesized in the presence of streptomycin in infected cells. At the time of incorporation of the labeled amino acid, more than 50% of the protein being synthesized in the control culture was coat protein.
Analysis Addition of phenylmethane sulfonyl fluoride (400 to 500 ,ug/ml), an inhibitor of serine endopeptidases, had no effect on protein degradation in either the uninfected or R17-infected cells. This protease inhibitor at these concentrations has been reported to prevent the breakdown of protein in cells starved for a carbon or nitrogen source, but not in cells which have accumulated abnormal protein as a result of incorporation of amino acid analogues (16 (4, 5, 14, 15). Pine (14) and Goldberg (4) have shown the vulnerability to proteolytic attack of proteins synthesized in the presence of amino acid analogues including canavanine, thienylalanine, fluorophenylalanine, and norleucine. Both investigators have shown that labeied amino acid incorporated in the presence of these agents was exceptionally sensitive to release into the acidsoluble form. Experiments of Goldschmidt (5), in which potentiated catabolism of a fragment of ,8-galactosidase was demonstrated, and Platt (15) , illustrating the increased susceptibility of an abnormal lac repressor to proteolysis, further indicate a mechanism in E. coli for the selective degradation of atypical proteins.
Our evidence indicates that a substantial portion of the protein synthesized in the presence of streptomycin in a mutant in which the lethal effect has been delayed is highly susceptible to degradation. By analogy with the forementioned studies, this protein undoubtedly is abnormal. Although the nature of the aberrancy cannot be determined directly from these data it seems likely that the degree of error ranges considerably. Proteins with few changes in amino acid sequence may be assayed as active enzyme. Recent findings of Gorini and associates (1) demonstrate low levels of jB-galactosidase activity in lac frameshift mutants, suggesting that proteins with some level of inaccurate translation can be active. Substantial crossreacting, but apparently enzymatically inactive, material is also found in these cells. Such material could be either miscoded so as to affect the structure of the active site of the enzyme but still leave antigenically reactive sites intact or could, in the case of f-galactosidase, be large fragments resulting from premature chain termination. In the case of the coat protein of R17, it seems unlikely that fragments of this small protein (molecular weight approximately 14,000) would be precipitated with antiphage serum. Thus, the possibility of premature chain termination cannot be ruled out but seems less likely in light of the amount of CRM found particularly. with the small structural protein.
It is interesting to note that in the flow of labeled amino acid into protein there was a greater association of newly synthesized peptide with the membrane fraction in streptomycintreated cells than in the control. This could reflect an effect of streptomycin on the integrity of the membrane or could be related to the recent finding of Prouty and Goldberg (17) that certain proteins destined for degradation are found in aggregate form in a rapidly sedimenting fraction of cell lysates.
It also seems clear that the production of abnormal protein (enzymatically inactive and susceptible to proteolysis) can be separated from the lethal effect of streptomycin by the use of mutants with ribosomal alterations. The bactericidal effect appears linked to an event in the protein synthesis cycle leading to cessation of amino acid incorporation. This event occurs rapidly in wild-type streptomycin-sensitive cells, probably before much (or any) abnormal protein has accumulated, but is delayed in mutants, such as the one in this study, until substantial amounts of abnormal protein has been synthesized. Although the possibility that miscoding is involved in cell death in wild-type cells cannot be ruled out, the studies with mutants indicate that the streptomycininduced production of abnormal protein does not cause an immediate loss of viability.
All of the mutants, isolated in our laboratory, which show this separation of the miscoding and lethal effects result from alterations in the gene coding for ribosomal protein S4; other changes in S4 are responsible for the ram phenotype, resulting in ambiguity in translation (19) . Although little is known of the structural relationship of proteins S12 (the product of the strA locus) and S4 (the product of the ram locus), there is clearly a functional interaction between them, with mutations in the gene for S4 resulting in altered responses to streptomycin. By using various combinations of mutant S12 and S4, it may be possible to separate what appear to be the multiple effects of streptomycin, such as errors in translation, interference with one or more steps in the ribosome cycle leading to cessation of protein synthesis, and effects on cell division.
The possibility of such separable sites was suggested by Gorini (6) , who proposed that S4 may be at the site of codon recognition and be involved in misreading and that protein S12 may be at a "control" site. Such mutants might also be used to further investigate the proposal of Modolell and Davis (10) that streptomycin interacts with or affects both the "A" site and the "P" site of bacterial ribosomes.
